TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NOVOCURE INC. · Oncology company with novel therapy for solid tumors

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $80,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Medicare/Medicaid

Medicare coverage and reimbursement, national coverage determinations

Health Issues

FDA policies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.